Showing results (1681-1690 of 1,800) with videos related to

Sort By:
Pageof 180
Digestive Diseases and Sciences|September 9, 2021
Dynamic Risk Prediction of Response to Ursodeoxycholic Acid Among Patients with Primary Biliary Cholangitis in the USAJia Li, Mei Lu, Yueren Zhou, et al.
BMJ (Clinical Research Ed.)|May 16, 2022
Visualising harms in publications of randomised controlled trials: consensus and recommendationsRachel Phillips, Suzie Cro, Graham Wheeler, et al.
The Lancet. Gastroenterology & Hepatology|June 4, 2018
Deferred treatment with sofosbuvir-velpatasvir-voxilaprevir for patients with chronic hepatitis C virus who were previously treated with an NS5A inhibitor: an open-label substudy of POLARIS-1Marc Bourlière, Stuart C Gordon, Eugene R Schiff, et al.
American Journal of Medical Genetics. Part A|December 5, 2012
Clinical utility of the X-chromosome arrayYuri A Zarate, Alka Dwivedi, Frank O Bartel, et al.
Lancet (London, England)|March 19, 2013
Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trialKris V Kowdley, Eric Lawitz, Israel Crespo, et al.
Cardiovascular and Interventional Radiology|June 22, 2022
Yttrium-90 Radioembolization of Unresectable Intrahepatic Cholangiocarcinoma: Long-Term Follow-up for a 136-Patient CohortAakash N Gupta, Andrew C Gordon, Ahmed Gabr, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 10, 2008
Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infectionDamon P Eisen, Melinda M Dean, Marja A Boermeester, et al.
Blood|July 15, 1997
Bone marrow transplantation for severe aplastic anemia: has outcome improved?J R Passweg, G Socié, W Hinterberger, et al.
Science (New York, N.Y.)|October 19, 2023
A luminous fast radio burst that probes the Universe at redshift 1S D Ryder, K W Bannister, S Bhandari, et al.
The American Journal of Gastroenterology|June 24, 2025
Long-Term Efficacy and Safety of Selective PPARδ Agonist Seladelpar in Primary Biliary Cholangitis: ASSURE Interim Study ResultsCynthia Levy, Palak J Trivedi, Kris V Kowdley, et al.
Pageof 180